$1.20
At close: Apr 10 EDT
$1.33
0.1310.83%
Pre-Market: 7:11 AM EDT
Comments
Loading...
TScan Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:TCRX | Benzinga
TScan Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 12
EPS Estimate
$-0.280
Quarterly Revenue Estimate
$1.08M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$2.82M
Analyze the earnings history of TScan Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| TCRX | TScan Therapeutics | -$0.32 | -$0.28 | — | — | $566.00K | $1.08M | — | — | 05/12/2025 | Get Alert |
| TCRX | TScan Therapeutics | -$0.21 | -$0.28 | -$0.29 | -3.57% | $7.21M | $1.51M | $665.00K | -55.96% | 03/05/2025 | Get Alert |
| TCRX | TScan Therapeutics | -$0.24 | -$0.29 | -$0.25 | 13.79% | $3.89M | $1.06M | $1.05M | -1.04% | 11/12/2024 | Get Alert |
| TCRX | TScan Therapeutics | -$0.51 | -$0.28 | -$0.28 | 0.00% | $3.15M | $2.42M | $536.00K | -77.85% | 08/12/2024 | Get Alert |
| TCRX | TScan Therapeutics | -$0.93 | -$0.25 | -$0.32 | -28.00% | $6.80M | $3.97M | $566.00K | -85.74% | 05/13/2024 | Get Alert |
| TCRX | TScan Therapeutics | -$0.78 | -$0.29 | -$0.21 | 27.59% | $3.10M | $3.34M | $7.21M | 115.90% | 03/06/2024 | Get Alert |
| TCRX | TScan Therapeutics | -$0.67 | -$0.45 | -$0.24 | 46.67% | $3.36M | $4.09M | $3.89M | -4.96% | 11/09/2023 | Get Alert |
| TCRX | TScan Therapeutics | -$0.63 | -$0.78 | -$0.51 | 34.62% | $4.06M | $4.03M | $3.15M | -21.89% | 08/10/2023 | Get Alert |
| TCRX | TScan Therapeutics | -$0.67 | -$0.74 | -$0.93 | -25.68% | $3.02M | $4.40M | $6.80M | 54.61% | 05/10/2023 | Get Alert |
| TCRX | TScan Therapeutics | $0.38 | -$0.70 | -$0.78 | -11.43% | $2.85M | $3.82M | $3.10M | -18.95% | 03/08/2023 | Get Alert |
| TCRX | TScan Therapeutics | -$0.80 | -$0.72 | -$0.67 | 6.94% | $2.41M | $3.70M | $3.36M | -9.11% | 11/09/2022 | Get Alert |
| TCRX | TScan Therapeutics | -$7.69 | — | -$0.63 | — | $2.85M | — | $4.06M | — | 08/10/2022 | Get Alert |
| TCRX | TScan Therapeutics | -$6.49 | — | -$0.67 | — | $2.03M | — | $3.02M | — | 05/09/2022 | Get Alert |
| TCRX | TScan Therapeutics | — | — | $0.38 | — | — | — | $2.85M | — | 03/09/2022 | Get Alert |
| TCRX | TScan Therapeutics | -$7.16 | — | -$0.80 | — | $290.00K | — | $2.41M | — | 11/10/2021 | Get Alert |
| TCRX | TScan Therapeutics | -$6.18 | — | -$7.69 | — | — | — | $2.85M | — | 08/19/2021 | Get Alert |
TScan Therapeutics (TCRX) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-05 | $-0.29 | $-0.28 | -3.57 % |
| Q3 | 2024-11-12 | $-0.25 | $-0.29 | 13.8 % |
| Q2 | 2024-08-12 | $-0.28 | $-0.28 | 0.00 % |
| Q1 | 2024-05-13 | $-0.32 | $-0.25 | -28.0 % |
TScan Therapeutics (TCRX) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-05 | $665.00K | $1.51M | -56.0 % |
| Q3 | 2024-11-12 | $1.05M | $1.06M | -1.04 % |
| Q2 | 2024-08-12 | $536.00K | $2.42M | -77.8 % |
| Q1 | 2024-05-13 | $566.00K | $3.97M | -85.7 % |
FAQ
When is TScan Therapeutics (NASDAQ:TCRX) reporting earnings?
TScan Therapeutics (TCRX) is scheduled to report earnings on May 12, 2025. The last reported earnings were for reported on March 5, 2025 for Q4.
What were the latest earnings per share (EPS) for TScan Therapeutics (NASDAQ:TCRX)?
The Actual EPS was $-0.29, which missed the estimate of $-0.28.
What were TScan Therapeutics’s (NASDAQ:TCRX) revenues?
The Actual Revenue was $665K, which missed the estimate of $1.5M.
Browse earnings estimates, EPS, and revenue on all stocks.